LIFECORE BIOMEDICAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
LIFECORE BIOMEDICAL, INC. (LFCR) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $30.92 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-05
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $30.92M.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $29.72M.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $26.56M.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $25.49M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2026-06-30 | $30.92M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $29.72M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $26.56M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $25.49M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $25.12M 10-Q · filed 2025-11-06 |
| 2025-05-25 | $24.99M 10-Q · filed 2026-08-05 |
| 2025-02-23 | $23.90M 10-Q · filed 2026-08-05 |
| 2024-11-24 | $23.30M 10-Q · filed 2026-08-05 |
| 2024-08-25 | $24.50M 10-Q · filed 2025-11-06 |
| 2024-05-26 | $25.40M 10-KT · filed 2026-03-16 |
| 2024-02-25 | $23.00M 10-Q · filed 2025-04-03 |
| 2023-11-26 | $44.00M 10-Q · filed 2025-04-03 |
| 2023-08-27 | $64.70M 10-Q · filed 2025-01-02 |
| 2023-05-28 | $64.90M 10-KT · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |